Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors

This study has been completed.
Sponsor:
Collaborator:
Georgetown University
Information provided by:
INSYS Therapeutics Inc
ClinicalTrials.gov Identifier:
NCT00024661
First received: September 24, 2001
Last updated: April 12, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: October 2004
  Estimated Primary Completion Date: No date given